- Home
- CTNM vs ACP Comparison
CTNM vs ACP Comparison
Compare CTNM & ACP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- ACP
- Stock Information
- Founded
- CTNM 2009
- ACP 2010
- Country
- CTNM United States
- ACP United States
- Employees
- CTNM N/A
- ACP N/A
- Industry
- CTNM
- ACP Investment Managers
- Sector
- CTNM
- ACP Finance
- Exchange
- CTNM Nasdaq
- ACP Nasdaq
- Market Cap
- CTNM 377.6M
- ACP 336.6M
- IPO Year
- CTNM 2024
- ACP N/A
- Fundamental
- Price
- CTNM $11.28
- ACP $6.05
- Analyst Decision
- CTNM Strong Buy
- ACP
- Analyst Count
- CTNM 4
- ACP 0
- Target Price
- CTNM $29.25
- ACP N/A
- AVG Volume (30 Days)
- CTNM 135.4K
- ACP 337.9K
- Earning Date
- CTNM 02-16-2025
- ACP 01-01-0001
- Dividend Yield
- CTNM N/A
- ACP 17.79%
- EPS Growth
- CTNM N/A
- ACP N/A
- EPS
- CTNM N/A
- ACP N/A
- Revenue
- CTNM N/A
- ACP N/A
- Revenue This Year
- CTNM N/A
- ACP N/A
- Revenue Next Year
- CTNM N/A
- ACP N/A
- P/E Ratio
- CTNM N/A
- ACP N/A
- Revenue Growth
- CTNM N/A
- ACP N/A
- 52 Week Low
- CTNM $11.38
- ACP $5.55
- 52 Week High
- CTNM $22.00
- ACP $7.17
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- ACP 47.89
- Support Level
- CTNM N/A
- ACP $5.92
- Resistance Level
- CTNM N/A
- ACP $6.17
- Average True Range (ATR)
- CTNM 0.00
- ACP 0.06
- MACD
- CTNM 0.00
- ACP 0.03
- Stochastic Oscillator
- CTNM 0.00
- ACP 53.70
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.